RALEIGH, N.C., June 20, 2011 /PRNewswire/ — Pharmaceutical
Institute, the leading provider of specialized training solutions
for the pharmaceutical and biotech industry and a subsidiary of
Campbell Alliance, announced today the completion of 2011 updates
to its Therapeutic Area Essentials™ e-course
series. This series delivers in-depth disease state training
for pharmaceutical and biotech R&D and commercial
professionals. It includes 155 e-courses covering the
diagnosis, cause, and treatment for more than 45 disease
Therapeutic Area Essentials™ provides
the pharmaceutical and biotech industry with a single source for
current and comprehensive disease state training. All courses
have been updated in 2011 by Pharmaceutical Institute’s content
scientists and physician experts. Updates reflect the most
current disease state knowledge such as prevalence and incidence
statistics, disease understanding (including cause, risk factors,
and progression), diagnostic procedures, and treatment guidelines.
“Providing pharma and biotech employees with immediate,
needs-based access to high quality disease state training can
deliver significant value,” says Garry O’Grady, Senior Vice
President and General Manager of Pharmaceutical Institute.
“We’re pleased to provide a go-to resource for high-quality
training content across the therapeutic area spectrum.”
Core therapeutic areas covered by Therapeutic Area
Essentials™ include cardiology and metabolic
disorders, gastroenterology, infections, musculoskeletal,
neurology, oncology, ophthalmology, and respiratory disorders.
The series also provides anatomy and physiology training for
each of these systems.
For more information on the Therapeutic Area
Essentials™ training solutions, including a
complete list of courses, please visit: